Maintelyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

The formulation supplies magnesium, potassium, sodium, chloride, acetate and glucose directly into the bloodstream. These ions replenish depleted stores, restore osmotic balance, and support cellular functions, while glucose provides energy and acetate contributes to buffering, enabling rapid correction of fluid and electrolyte disturbances.

The prescribed dose of Maintelyte is determined by the treating clinician based on the patient’s electrolyte levels, fluid status, weight, and clinical condition. Dosing is individualized and administered under medical supervision.

Safety data for Maintelyte in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Maintelyte, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Maintelyte offers a balanced combination of magnesium, potassium, sodium, chloride, acetate and glucose, making it suitable for patients needing multiple electrolyte corrections simultaneously. Compared with single‑ion solutions, it can address several deficiencies in one infusion, potentially reducing the number of separate administrations.

Maintelyte should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use to maintain stability and sterility.

Maintelyte is administered intravenously by a healthcare professional. The solution is typically infused through a peripheral or central line, with the rate adjusted according to the patient’s clinical status, electrolyte targets and fluid balance requirements.

Serious risks include severe electrolyte imbalances such as hypermagnesemia or hyperkalemia, anaphylactic reactions, and cardiac arrhythmias caused by rapid shifts in ion concentrations. Continuous monitoring of electrolytes and cardiac rhythm is essential during infusion.

Maintelyte should be avoided in patients with known hypersensitivity to any of its components, in those with severe renal failure where electrolyte clearance is compromised, and in individuals receiving other high‑volume IV electrolyte solutions without appropriate monitoring.